[Harry Dorchy and pediatric diabetology]

Stuart J Brink1

  • 1New England Diabetes and Endocrinology Center (NEDEC), Waltham, MA 02451-1136, USA. stubrink@aol.com

Insights

Professor Harry Dorchy, a leader in pediatric diabetes care, is retiring after a distinguished 40-year career. His work has significantly advanced the treatment and understanding of diabetes in children and adolescents globally.

Area of Science:

  • Pediatric Endocrinology
  • Diabetology
  • Clinical Research

Background:

  • Professor Harry Dorchy's career spans 40 years, focusing on pediatric diabetes care and research.
  • He co-established a legacy of clinical care and innovative thinking for young people with diabetes.
  • Dr. Dorchy's patients at Queen Fabiola University Children's Hospital demonstrate exceptional glycemic control.

Discussion:

  • Dr. Dorchy's research encompasses screening for complications, diet, physical activity, glycemic control, and quality of life in pediatric diabetes.
  • His work has contributed to understanding genetics, immunology, and specific types of diabetes in youth.
  • He has been a key figure in international collaborations, including the Hvidoere International Study Group.

Key Insights:

  • Dr. Dorchy's patient cohort achieved the lowest hemoglobin A1c levels within the Hvidoere International Study Group, indicating superior diabetes management.
  • This success was achieved without excessive hypoglycemia, highlighting a balanced approach to treatment.
  • His extensive publication record reflects a deep and impactful contribution to the field.

Outlook:

  • Professor Dorchy's mentorship and teaching have influenced the next generation of pediatric diabetologists.
  • His collaborative efforts in Romania have fostered international knowledge exchange in diabetes care.
  • The legacy of his research and clinical practice will continue to shape pediatric diabetes management worldwide.

Related Concept Videos

Diabetes Insipidus I: Introduction01:29

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...